Skin manifestations of secondary dyslipidemia: a case report

Author:

Kim Z. F.1ORCID,Galyavich A. S.2ORCID,Nurieva I. M.1ORCID,Bayazova N. I.3ORCID

Affiliation:

1. Kazan State Medical University; City Clinical Hospital № 7

2. Kazan State Medical University

3. City Clinical Hospital № 7

Abstract

In the presented case report, 27-year-old female patient consulted a dermatologist and a lipidologist due to the appearance of small red spots on the skin. At the stage of examination in the lipid center, the patient was diagnosed with diabetes. During additional examination in the department of endocrinology, the following diagnosis was made: "Newlu-diagnosed type 1 diabetes. Target glycated hemoglobin level 6,5%. Secondary dyslipidemia. Skin xanthomatosis". After the start of therapy, laboratory parameters improved and the number of eruptive xanthomas decreased. Eruptive xanthomatosis in clinical practice is rare, and requires apprehensive attitude of doctors of various specialties. Timely detection of lipid metabolism disorders allows patients to recommend not only rational measures to prevent the development and progression of atherosclerosis, but also to diagnose the causes of secondary dyslipidemia.

Publisher

Silicea - Poligraf, LLC

Subject

Cardiology and Cardiovascular Medicine

Reference6 articles.

1. Ishevskaia OP, Namitokov AM, Kruchinova SV, et al. Familial hypercholesterolemia: case series of a rare condition. Russian Journal of Cardiology. 2021;26(3S):4610. (In Russ.) doi:10.15829/1560-4071-2021-4610.

2. Surkichin SI, Gryazeva NV. Eyelid xanthelasma and its management. Medical alphabet. 2019;1(7):63-4. (In Russ.) doi:10.33667/2078-5631-2019-1-7(382)-63-64.

3. Pankratov VG. Xanthomatosis of the skin and mucous membranes as a manifestation of dyslipidemia. Meditsinskie novosti. 2014;6:15-20. (In Russ.)

4. Kukharchuk VV, Ezhov MV, Sergienko IV, et al. Diagnostics and correction of lipid metabolism disorders in order to prevent and treat of atherosclerosis Russian recommendations VII revision. Аtherosclerosis and dyslipidemia. 2020;1(38):7-41. doi:10.34687/2219-8202.JAD.2020.01.0002.

5. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Russian Journal of Cardiology. 2020;25(5):3826. (In Russ.) doi:10.15829/1560-4071-2020-3826.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3